Clinical and neurophysiological characterization of muscular weakness in severe COVID-19.

ABSTRACT:

Objective

To report clinical and electroneuromyographic (ENMG) characteristics of patients affected by severe COVID-19 infection, evaluated for muscular weakness.

Materials and methods

ENMGs performed for evaluation of diffuse weakness in patients who could not be discharged from semi-intensive care COVID unit because of difficulties in ventilation weaning were reviewed. Patients with severe COVID-19 infection who had undergone endotracheal intubation and able to co-operate were considered. ENMG protocol was focused on neurophysiological items that excluded or confirmed critical illness polyneuropathy (CIP), myopathy (CIM), or polyneuromyopathy (CIPM). Standardized clinical evaluation was performed using Medical Research Council (MRC) sum score.

Results

Eight patients

SUBMITTER: Bax F 

PROVIDER: S-EPMC7985745 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature